Authors: Houba, PHJ Boven, E van der Meulen-Muileman, IH Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ

Citation: Phj. Houba et al., Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate, INT J CANC, 91(4), 2001, pp. 550-554

Authors: Houba, PHJ Boven, E van der Meulen-Muileman, IH Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ

Citation: Phj. Houba et al., A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer, BR J CANC, 84(4), 2001, pp. 550-557

Authors: Leenders, RGG Damen, EWP Bijsterveld, EJA Scheeren, HW Houba, PHJ van der Meulen-Muileman, IH Boven, E Haisma, HJ

Citation: Rgg. Leenders et al., Novel anthracycline-spacer-beta-glucuronide, -beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy, BIO MED CH, 7(8), 1999, pp. 1597-1610

Authors: Houba, PHJ Boven, E van der Meulen-Muileman, IH Leenders, RGG Scheeren, JW Pinedo, HM Haisma, HJ

Citation: Phj. Houba et al., Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenografts, BIOCH PHARM, 57(6), 1999, pp. 673-680